Abacus Planning Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.35M | Hold |
3,730
| – | – | 0.17% | 74 |
|
|
2026
Q1 | $1.31M | Sell |
3,730
-166
| -4% | -$59.2K | 0.18% | 69 |
|
|
2025
Q4 | $1.28M | Buy |
3,896
+83
| +2% | +$26.3K | 0.17% | 71 |
|
|
2025
Q3 | $1.08M | Sell |
3,813
-45
| -1% | -$13.1K | 0.15% | 81 |
|
|
2025
Q2 | $1.08M | Buy |
3,858
+4
| +0.1% | +$1.13K | 0.16% | 78 |
|
|
2025
Q1 | $1.2M | Buy |
3,854
+164
| +4% | +$48.4K | 0.21% | 66 |
|
|
2024
Q4 | $962K | Buy |
3,690
+14
| +0.4% | +$4.15K | 0.17% | 79 |
|
|
2024
Q3 | $1.18M | Sell |
3,676
-718
| -16% | -$235K | 0.21% | 67 |
|
|
2024
Q2 | $1.37M | Buy |
4,394
+34
| +0.8% | +$9.99K | 0.27% | 54 |
|
|
2024
Q1 | $1.24M | Hold |
4,360
| – | – | 0.24% | 58 |
|
|
2023
Q4 | $1.26M | Sell |
4,360
-27
| -0.6% | -$7.36K | 0.26% | 53 |
|
|
2023
Q3 | $1.18M | Sell |
4,387
-7
| -0.2% | -$1.75K | 0.29% | 52 |
|
|
2023
Q2 | $976K | Buy |
4,394
+100
| +2% | +$23.2K | 0.24% | 64 |
|
|
2023
Q1 | $1.04M | Hold |
4,294
| – | – | 0.27% | 57 |
|
|
2022
Q4 | $1.13M | Sell |
4,294
-28
| -0.6% | -$7.51K | 0.31% | 54 |
|
|
2022
Q3 | $974K | Buy |
4,322
+220
| +5% | +$53.3K | 0.29% | 54 |
|
|
2022
Q2 | $998K | Hold |
4,102
| – | – | 0.29% | 55 |
|
|
2022
Q1 | $992K | Sell |
4,102
-7
| -0.2% | -$1.61K | 0.27% | 69 |
|
|
2021
Q4 | $924K | Hold |
4,109
| – | – | 0.25% | 79 |
|
|
2021
Q3 | $874K | Sell |
4,109
-144
| -3% | -$33.1K | 0.28% | 67 |
|
|
2021
Q2 | $1.04M | Buy |
4,253
+145
| +4% | +$35.7K | 0.32% | 58 |
|
|
2021
Q1 | $1.02M | Hold |
4,108
| – | – | 0.33% | 62 |
|
|
2020
Q4 | $945K | Buy |
4,108
+172
| +4% | +$39.7K | 0.29% | 63 |
|
|
2020
Q3 | $1M | Hold |
3,936
| – | – | 0.36% | 55 |
|
|
2020
Q2 | $928K | Hold |
3,936
| – | – | 0.38% | 55 |
|
|
2020
Q1 | $798K | Buy |
3,936
+6
| +0.2% | +$1.31K | 0.39% | 53 |
|
|
2019
Q4 | $947K | Sell |
3,930
-21
| -0.5% | -$4.63K | 0.43% | 48 |
|
|
2019
Q3 | $765K | Buy |
3,951
+12
| +0.3% | +$2.3K | 0.38% | 57 |
|
|
2019
Q2 | $726K | Sell |
3,939
-56
| -1% | -$10K | 0.44% | 51 |
|
|
2019
Q1 | $759K | Sell |
3,995
-24
| -0.6% | -$4.58K | 0.47% | 50 |
|
|
2018
Q4 | $782K | Buy |
4,019
+30
| +0.8% | +$5.85K | 0.59% | 40 |
|
|
2018
Q3 | $826K | Sell |
3,989
-187
| -4% | -$36.9K | 0.55% | 39 |
|
|
2018
Q2 | $770K | Buy |
4,176
+15
| +0.4% | +$2.65K | 0.58% | 40 |
|
|
2018
Q1 | $709K | Sell |
4,161
-105
| -2% | -$19.3K | 0.58% | 40 |
|
|
2017
Q4 | $742K | Buy |
+4,266
| New | +$755K | 0.75% | 31 |
|
Other funds holding AMGN
Abacus Planning Group's AMGN Position: Q2 2026 in Review
Abacus Planning Group held its Amgen (AMGN) position steady in Q2 2026 at 3,730 shares worth $1.35M. The position accounts for 0.17% of the portfolio, ranked #74.
Abacus Planning Group first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.37M in Q2 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Abacus Planning Group held 3,730 shares of Amgen worth $1.35M as of Q2 2026.
- Abacus Planning Group left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.17% of Abacus Planning Group's portfolio in Q2 2026, its #74 holding.
- Abacus Planning Group first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
- Abacus Planning Group's Amgen position peaked at $1.37M in Q2 2024.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.